We rank companies based on fund manager, research analyst and news sentiment
BIO.B stock icon

Bio-Rad Laboratories Class B


About: Bio-Rad Laboratories Inc manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. It operates in two industry segments; In Clinical Diagnostics segment, the company manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In Life Sciences segment, the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with majority of the revenue being generated from United States, it also has its presence in Europe, Asia, Canada and other regions.

Employees: 8,030

Funds holding %
of 6,474 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

0.04% less ownership

Funds ownership: 0.11% [Q3] → 0.07% (-0.04%) [Q4]

25% less funds holding

Funds holding: 8 [Q3] → 6 (-2) [Q4]

42% less capital invested

Capital invested by funds: $2M [Q3] → $1.16M (-$837K) [Q4]

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Research analyst outlook

We haven’t received any recent analyst ratings for BIO.B.

Financial journalist opinion

We haven’t received any recent news articles for BIO.B.